Oncology Analytics
Scott Warshaw is an accomplished financial executive currently serving as Chief Financial Officer at OncoHealth since November 2023. Previously, Scott held the position of Chief Strategy Officer at XIFIN, Inc. from October 2022 to October 2023. Scott's extensive experience at OmniSYS from January 2010 to October 2022 included roles as Chief Financial Officer, VP of Finance & Strategy, Director of Corporate Strategy, and Business Development, focusing on enhancing healthcare workflows and patient interactions. Earlier in Scott's career, positions at Ernst & Young as an Assurance and Advisory Associate from September 2008 to January 2010 enriched financial and strategic expertise. Scott's education includes a BBA and MPA from the Texas McCombs School of Business, a BBA from The University of Texas at Austin, and a Professional Development Certificate from Harvard University.
This person is not in any teams
This person is not in any offices
Oncology Analytics
Oncology Analytics, Inc. provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, the e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care